Analysed LUNAI BIOWORKS INC (LNAI:NASDAQ) News Sources
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model
19-03-2026
yahoo.com
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications
26-03-2026
yahoo.com
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion
07-04-2026
yahoo.com
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships
15-04-2026
yahoo.com
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
04-05-2026
yahoo.com
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
06-05-2026
yahoo.com
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
28-05-2026
yahoo.com
What is the current price of LUNAI BIOWORKS INC (LNAI:NASDAQ)?
The current price of LUNAI BIOWORKS INC (LNAI:NASDAQ) is $2.845.
LUNAI BIOWORKS INC (LNAI:NASDAQ) absolute price change since previous trading day?
The absolute price change of LUNAI BIOWORKS INC (LNAI:NASDAQ) since the previous trading day is $0.235.
LUNAI BIOWORKS INC (LNAI:NASDAQ) percentage price change since previous trading day?
The percentage price change of LUNAI BIOWORKS INC (LNAI:NASDAQ) since the previous trading day is 9.0038%.
What is the most recent average sentiment score for LUNAI BIOWORKS INC (LNAI:NASDAQ)?
The most recent average sentiment score for LUNAI BIOWORKS INC (LNAI:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for LUNAI BIOWORKS INC (LNAI:NASDAQ)?
The most recent sentiment for LUNAI BIOWORKS INC (LNAI:NASDAQ) is .
SEC-8K** Filing Available For LUNAI BIOWORKS INC (LNAI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.